Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008

rance, legal and professional fees

associated with being a public company.

Employee stock-based compensation expense recorded in the fourth

quarter of 2007 was $5.2 million. Of the total $5.2 million of

non-cash charges, $1.0 million was recorded in R&D expenses and

$4.2 million was recorded in G&A expenses. In the third quarter of

2007 and the fourth quarter of 2006, total stock-based compensation was

$5.2 million and $1.6 million, respectively. For the full year of

2007, total stock-based compensation was $19.5 million, up from

$6.1 million in the prior year. The increase in stock-based

compensation is primarily the result of the higher fair value of

options granted during 2007 compared to options granted in prior

periods.

-- Net loss for the fourth quarter of 2007 was $20.7 million. This

compares to a net loss of $21.9 million in the third quarter of 2007,

and $11.9 million in the fourth quarter of 2006. For the full year of

2007, net loss was $74.1 million, up from $63.5 million for the full

year of 2006.

-- Net loss per common share for the fourth quarter of 2007 was $0.78,

compared to $0.82 in the third quarter of 2007 and $0.54 in the fourth

quarter of 2006. For the full year of 2007, net loss per common share

was $2.81, compared to $3.97 in the full year of 2006.

-- Cash and marketable securities decreased by $16.2 million during the

fourth quarter. Changes included $20.7 million of net losses and

decreases in accrued R&D expenses and accounts payable of $2.5 million,

offset by $5.3 million in non-cash depreciation, amortization, and

stock-based compensation expenses, decreases in prepaid expenses of

$1.6 million and net decreases in other working capital of

$0.1 million.

-- Vanda's cash, cash equivalents, an
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vion Pharmaceuticals Holds Special Meeting of Stockholders
2. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
4. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
9. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 /PRNewswire/ ... of an Irys™System by BGI , ... to enable comprehensive exploration of human structural variation (SV) ... of interest, including those where no reference exists. In ... new methods for multiplexing on the Irys System, enabling ...
(Date:7/31/2014)... July 31, 2014 “Rapid technological ... across the U.S., increasing unemployment, depressing American consumer ... It is a Catch 22—we need automated manufacturing ... means fewer jobs,” says economist and corporate relocation ... Corporate Top 10 Pro-Business States for 2014, co-published ...
(Date:7/31/2014)... 31, 2014 Sales Horizons, a leader ... online sales training course – Mastering the Complex ... performance. , Drawn from proven sales training programs used ... the Complex Sale online sales training course is available ... has face-to-face contact with customers, like technical support, engineers, ...
(Date:7/30/2014)... 30, 2014 A study presented at ... and efficacy of CSL Behring,s C1 Inhibitor (C1-INH) ... in highly sensitized patients. C1-INH is a human ... system. The study shows that post-transplant ... the levels of complement components 3 and 4, ...
Breaking Biology Technology:BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3
... Catapult Systems , a leading Microsoft IT ... Microsoft SharePoint 2010 and FAST implementation for Array BioPharma, ... commercialization of targeted small molecule drugs to treat patients ... Earlier this year, Array conducted a proof of concept ...
... Inc. (OTC Bulletin Board: WDST ) a biotechnology ... restore the health of damaged tissues and organs, today announced ... viewing. LINK: www.retailinvestorconferences.com ... 90 days. Investors may download shareholder materials from the "virtual ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... targeting the extracellular matrix for the ... reported financial results for the third quarter ended ... http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100302/LA63139LOGO ) ...
Cached Biology Technology:Catapult Systems Awarded SharePoint 2010 and FAST Intranet Project 2Catapult Systems Awarded SharePoint 2010 and FAST Intranet Project 3Regenicin Presentation Now Available Online at RetailInvestorConferences.com 2Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 2Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 3Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 4Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 5Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 6Halozyme Therapeutics Reports Third Quarter 2010 Financial Results 7
(Date:7/31/2014)... make a rational choice to be liberal or conservative? ... a matter of genetics?, Two political scientists from the ... say that neither conscious decision-making nor parental upbringing fully ... right. , A growing body of evidence shows that ... of political differences, the researchers say in the latest ...
(Date:7/31/2014)... In the same week that the U.S. surgeon general ... cancer, researchers at Montana State University published a paper ... code in every cell responds when exposed to ... of DNA damage by the UV rays found in ... and some degenerative eye diseases. , "Our paper ...
(Date:7/31/2014)... found that bacteria in the Gulf of Mexico consumed ... during the Deepwater Horizon spill in the months after ... In two new studies conducted in a deep sea ... bacteria called Colwellia likely consumed gaseous hydrocarbons ... were released as part of the oil spill. ...
Breaking Biology News(10 mins):Scientists find growing consensus: Political attitudes derive from body and mind 2New paper describes how DNA avoids damage from UV light 2New paper describes how DNA avoids damage from UV light 3
... human activity and the extinction of species around the ... a Canadian zoologist. This ecological damage also endangers human ... Dr. Daniel (Dan) Brooks, a parasitologist at the University ... linked to the emergence of new human and wildlife ...
... doing or reading a paper about microarray-based experiments,reproductibility, especially ... If I redo the same experiment in one month, ... demonstrated that microarrays experiments performed in different labs ... , as long as standardized protocols are carefully followed". ...
... study to examine the probability of,HIV infection per act ... has found that uncircumcised men have more,than twice the ... study, published in the Feb. 15 issue of The ... colleagues,from the United States and Kenya collected detailed sexual ...
Cached Biology News:Ecological destruction fuels emerging diseases 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3Male circumcision reduces risk of HIV transmission from women to men 2
... Leukemia Virus Reverse Transcriptase (M-MLV RT) is an ... cDNA synthesis with long messenger RNA templates (>5kb). ... gene of M-MLV and consists of a single ... RNase H activity of M-MLV RT is weaker ...
... the determination of digitonin and digoxin. Physical form: ... 4 and 0.06% NaCl Preparation Note: Sodium ... Biophys. Res. Commun., 19, 755 (1965). Unit ... inorganic phosphorus from ATP per min at pH ...
kismet (dK-20)...
... Thermo Hybaid's unique Electro-4 design allows "4 ... Electro-4 it is possible to run 200,samples ... by stacking up to four,horizontal gels. To ... according to the number of gels being ...
Biology Products: